FINAL REFUSAL - MAILED
mailed
on 27 Nov 2024
Last Applicant/ Owned by
305 College Road East
Princeton
NJ
08540
Serial Number
98208262 filed on 03rd Oct 2023
Registration Number
N/A
Correspondent Address
Kevin M. Bovard
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ENTERICA
Therapeutic agent, namely, chemicals in the nature of internally administered therapeutic sorbents in the form of synthetic, polymeric, and processed natural materials for pharmaceutical purposes that reduce cytokines, toxins, bile acids, and other inflammatory mediators intraluminally to treat both local and systemic inflammation and tissue injury.
Classification Information
Class [005]
Pharmaceutical Products
Therapeutic agent, namely, chemicals in the nature of internally administered therapeutic sorbents in the form of synthetic, polymeric, and processed natural materials for pharmaceutical purposes that reduce cytokines, toxins, bile acids, and other inflammatory mediators intraluminally to treat both local and systemic inflammation and tissue injury.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98208262
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 100861.20059
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 27th Nov 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 27th Nov 2024 | FINAL REFUSAL E-MAILED |
| 27th Nov 2024 | FINAL REFUSAL WRITTEN |
| 25th Nov 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 25th Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 25th Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 23rd Aug 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 23rd Aug 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 23rd May 2024 | NON-FINAL ACTION E-MAILED |
| 23rd May 2024 | NON-FINAL ACTION WRITTEN |